GE Healthcare Hosts Visionary Cardiology Symposium; Dozens of American College of Cardiology Fellows Meet to Discuss a New Frontier in Cardiology

Contact:
GE Healthcare
Kristin Binns
262-617-8858
kristin.binns@ge.com

February 22, 2006

WAUKESHA, WIS. - GE Healthcare announced today that the company will host its third annual Cardiovascular Innovation Symposium for more than 30 cardiology chiefs of staff and representatives from the American College of Cardiology (ACC). The meeting which will be held at the John F. Welch Leadership Development Center on February 22, 2006, will facilitate the discussion of new protocols in the prediction, diagnosis, information, and treatment of heart disease.

According to Pamela Douglas MD, FACC, chief of cardiovascular medicine at Duke University Medical Center and president of the ACC, GE’s cardiovascular innovation symposiums have provided a unique forum for thought - leaders to come together and discuss important issues facing cardiologists today, including clinical advancements as well as business methods and management processes. “Our members have continually expressed their desire for additional leadership training to help better prepare them for the many demands they face outside of the patient care arena,” Douglas said.

Featured topics include:

  • GE’s career leadership development
  • Heart Failure: prevention of sudden cardiac death
  • Managing pre-clinical coronary artery disease
  • Improving decision – making in cardiovascular medicine

    This year’s symposium is just one of many upcoming GE Healthcare sponsored collaborations with the cardiology community, according to Laura King, Global Vice President of Interventional, Cardiology & Surgery at GE Healthcare.

    “The open dialogue created by these symposiums provides an outstanding opportunity for GE to collaborate with key thought leaders in cardiology, exchanging ideas on clinical advancements, and reiterating GE’s commitment to leading the way in the early diagnosis and treatment of heart disease,” said King.

    • About GE Healthcare

    GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.

    GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.

    Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at:  www.gehealthcare.com